- Home
- ANGO
ANGO
AngioDynamics Inc.
as 07-26-2024 4:00pm EST
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.
| Founded: | 1988 | Country: | United States |
| Employees: | N/A | City: | LATHAM |
| Market Cap: | 251.1M | IPO Year: | 2004 |
| Target Price: | $12.25 | AVG Volume (30 days): | 752.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.59 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.26 - $9.43 | Next Earning Date: | 07-16-2024 |
| Revenue: | $303,914,000 | Revenue Growth: | -10.28% |
| Revenue Growth (this year): | -13.49% | Revenue Growth (next year): | -0.02% |
Stock Insider Trading Activity of AngioDynamics Inc. (ANGO)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Clemmer James C | ANGO | President and CEO | Apr 8 '24 | Buy | $6.70 | 10,000 | $67,000.00 | 539,066 | SEC Form 4 |
Latest AngioDynamics Inc. News
ANGO Breaking Stock News: Dive into ANGO Ticker-Specific Updates for Smart Investing
Simply Wall St.
9 days ago
When Will AngioDynamics, Inc. (NASDAQ:ANGO) Breakeven?
Zacks
9 days ago
AngioDynamics (ANGO) Q4 Earnings Top Estimates, Gross Margin Down
Thomson Reuters StreetEvents
10 days ago
Q4 2024 AngioDynamics Inc Earnings Call
MT Newswires
10 days ago
Sector Update: Health Care Stocks Rise Late Afternoon
MT Newswires
10 days ago
AngioDynamics Shares Rise After Fiscal Q4 Results, Share Repurchase Program
Zacks
11 days ago
AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates
Associated Press Finance
11 days ago
AngioDynamics: Fiscal Q4 Earnings Snapshot
Business Wire
11 days ago
AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results
Compare ANGO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ANGO AngioDynamics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.